Lexicon Pharmaceuticals (LXRX) Net Cash Flow: 2009-2012
Historic Net Cash Flow for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2012 value amounting to $9.7 million.
- Lexicon Pharmaceuticals' Net Cash Flow fell 93.80% to $9.7 million in Q4 2012 from the same period last year, while for Dec 2012 it was -$155.9 million, marking a year-over-year decrease of 212.07%. This contributed to the annual value of $44.2 million for FY2024, which is 285.05% up from last year.
- Per Lexicon Pharmaceuticals' latest filing, its Net Cash Flow stood at $9.7 million for Q4 2012, which was up 174.22% from -$13.0 million recorded in Q3 2012.
- In the past 5 years, Lexicon Pharmaceuticals' Net Cash Flow registered a high of $159.6 million during Q1 2010, and its lowest value of -$164.8 million during Q4 2010.
- In the last 3 years, Lexicon Pharmaceuticals' Net Cash Flow had a median value of -$6.1 million in 2010 and averaged -$5.8 million.
- Per our database at Business Quant, Lexicon Pharmaceuticals' Net Cash Flow plummeted by 535.72% in 2010 and then spiked by 2,170.95% in 2012.
- Lexicon Pharmaceuticals' Net Cash Flow (Quarterly) stood at $37.8 million in 2009, then tumbled by 535.72% to -$164.8 million in 2010, then soared by 194.54% to $155.8 million in 2011, then tumbled by 93.80% to $9.7 million in 2012.
- Its last three reported values are $9.7 million in Q4 2012, -$13.0 million for Q3 2012, and $4.8 million during Q2 2012.